FDA Approves Second Generation of Simplot GMO Spuds
Source – Capital Press
By John O’Connell
Date – 13 Jan 2016
Website – www.capitalpress.com
J.R. Simplot Co.’s second-generation Innate potato has been approved by the federal Food and Drug Administration.
BOISE — The J.R. Simplot Co. announced Jan. 13 it has obtained federal Food and Drug Administration approval for the second generation of its Innate line of potatoes, developed with biotechnology.
The company plans to raise less than 100 acres of second-generation Innate Russet Burbanks this season in anticipation of approval by the U.S. Environmental Protection Agency, which is expected by December and would represent the final step in the review process.
Innate’s second generation was previously approved by USDA, and the company voluntarily sought FDA approval, said Simplot spokesman Doug Cole.
“(FDA approval) is something most all biotech companies will go through because it gives customers an assurance of safety,” Cole said. “We will pursue it for all of our various (Innate) generations.”
Innate lines utilize genes introduced through biotechnology from wild and cultivated potatoes, which has led to concerns by some in the industry that the product could affect foreign trade markets where consumers are wary of genetically modified organisms. The first generation of Innate, which offered low bruising, non-browning and low acrylamide, was approved by FDA last March and saw its first significant commercial production in 2015. The second generation includes the original traits, plus improved cold storage and late blight resistance.
Because of the late blight resistance trait, the second generation of Innate must also undergo review by EPA, which is tasked with assessing pesticides, despite the fact that the protection is incorporated into the plant.